HSBC Raises Tesla Price Target to $157
- Rating
- Sell
- Price target
- $157
- from $125
- Implied downside
- -58%
- vs $370.59 prior close
This callScored on Apr 6, 2027, six months after the note: did TSLA reach $157?
Firm track recordHSBC reached 46% of its 13 scored targets within six months (#27 of 30 firms); on Tesla, 0 of 2. Accuracy ranking →
HSBC analyst Michael Tyndall raised the price target on Tesla (NASDAQ: TSLA) to $157 (from $125) while maintaining a Reduce rating.
“3Q26 deliveries of 487k units were 7% above VA consensus, and 5% above company consensus and our estimate.
They were down 2%, which is a good result given the pull-forward impact in the base due to the end of IRA tax credits.
Much like 2Q, the actual result was substantially ahead of that projected based on publicly available registration/sales data. The delta was again close to 80k units.
Production of 464k units, 4.6% below VA consensus and 3.7% below our estimate, was also 23k below deliveries, which could suggest Tesla expects the current sales run-rate to slow, or might reflect summer shutdowns.
Energy Storage deployment at 13.7GWh was 19% below VA consensus and 24% below our estimate. This continues the trend of disappointments through this year.
Over the first three quarters, deployments have grown 11% YoY, not quite the 40% growth rate we had been initially looking for.
Tesla mentioned Energy and Storage Systems (ESS) deployments can be lumpy, but the softer performance seems at odds with strong growth we are see elsewhere in ESS (see China EV/ESS battery: The next wave of energy, 11 Jun 2026).
We trim our 2026 deployment forecast, but it still implies a 35% YoY growth rate in 4Q26e.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
